|
ARHGAP31 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.25169999815245E-08 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.92549999994607E-06 |
| Normal-vs-Stage2 |
5.475600E-03 |
| Normal-vs-Stage3 |
5.93289994910151E-09 |
| Normal-vs-Stage4 |
5.16142684148235E-13 |
| Stage1-vs-Stage2 |
4.233400E-01 |
| Stage1-vs-Stage3 |
2.636500E-02 |
| Stage1-vs-Stage4 |
1.8207999999964E-06 |
| Stage2-vs-Stage3 |
2.669600E-02 |
| Stage2-vs-Stage4 |
4.821700E-04 |
| Stage3-vs-Stage4 |
4.500000E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.1354000052406E-08 |
| Normal-vs-AfricanAmerican |
5.799800E-03 |
| Normal-vs-Asian |
5.62989999952634E-07 |
| Caucasian-vs-AfricanAmerican |
4.016000E-01 |
| Caucasian-vs-Asian |
6.924000E-01 |
| AfricanAmerican-vs-Asian |
2.749200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.01919999998079E-06 |
| Normal-vs-Female |
3.22800000063239E-08 |
| Male-vs-Female |
9.538800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.54084999999249E-05 |
| Normal-vs-Age(41-60Yrs) |
1.58500000013717E-07 |
| Normal-vs-Age(61-80Yrs) |
3.71199999960048E-07 |
| Normal-vs-Age(81-100Yrs) |
2.801800E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.440000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.342200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.029800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.159000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.072000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.546400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.11890000000525E-05 |
| Classical-VS-Follicular |
6.823400E-01 |
| Classical-VS-Other |
3.461400E-01 |
| Classical-VS-Normal |
8.15599999981487E-07 |
| Tall-VS-Follicular |
2.033000E-04 |
| Tall-VS-Other |
6.287000E-01 |
| Tall-VS-Normal |
9.74598179936947E-12 |
| Follicular-VS-Other |
3.038200E-01 |
| Follicular-VS-Normal |
1.210930E-04 |
| Other-VS-Normal |
3.438400E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.02480000000005E-05 |
| Normal-vs-N1 |
3.00840463651753E-11 |
| N0-vs-N1 |
4.404400E-04 |
|
|
